Key Insights Significantly high institutional ownership implies Fulcrum Therapeutics' stock price is sensitive to their…
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Fulcrum Therapeutics, Inc. (NASDAQ:FULC) institutional owners may be pleased with recent gains after 31% loss over the past year